CLINICAL_TRIALS
research
· 2013-10-28
Clinical Trial Update: Malignancy Meta Analysis for BRL49653
Summary
Clinical trial update presenting a meta-analysis of malignancy risk for BRL49653 in Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED